With new therapies that promise to slow Alzheimer’s disease
WEBJul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
First Alzheimer’s drug to slow disease progression gets full FDA ...
WEBJul 7, 2023 · CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
WEBJul 28, 2024 · A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds - The New York Times. It was much more accurate than primary care doctors using cognitive tests and CT...
Second Alzheimer’s drug to slow disease’s progression may be
WEBJul 17, 2023 · The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been...
New Treatment Reverses Alzheimer’s Disease Signs
WEBDec 20, 2023 · PHILADELPHIA – A “chaperone” molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer’s disease, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
FDA approves new Alzheimer’s drug that appears to slow disease
WEBJan 6, 2023 · The Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness.
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
House Passes Bipartisan Legislation in Fight to End Alzheimer's
WEB5 days ago · House Passes Critical Bipartisan Legislation to Build on Progress in the Fight Against Alzheimer’s. — NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act head to White House to be signed into law —. Washington, D.C., September 23, 2024 — Today the U.S. House of Representatives unanimously passed critical ...
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
WEBJanuary 06, 2023. Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the...
Skip to content